DB2313 (DB 2313)
- CAS No.
- 2170606-74-1
- Chemical Name:
- DB2313 (DB 2313)
- Synonyms
- DB2313;DB2313 (HCl);DB2313 (DB 2313);DB2313 DB2313.4HCl;1H-Benzimidazole-6-carboximidamide, 2,2'-[(2-fluoro-1,3-phenylene)bis(methyleneoxy-4,1-phenylene)]bis[N-(1-methylethyl)-;2,2'-((((2-Fluoro-1,3-phenylene)bis(methylene))bis(oxy))bis(4,1-phenylene))bis(N-isopropyl-1H-benzo[d]imidazole-6-carboximidamide);2,2'-((((2-Fluoro-1,3-phenylene)bis(methylene))bis(oxy))bis(4,1-phenylene))bis(N-isopropyl-1H-benzo[d]imidazole-6-carboximidamide);2-[4-({2-fluoro-3-[(4-{6-[N-(propan-2-yl)carbamimidoyl]-1H-1,3-benzodiazol-2-yl}phenoxy)methyl]phenyl}methoxy)phenyl]-N-(propan-2-yl)-1H-1,3-benzodiazole-6-carboximidamide
- CBNumber:
- CB14844690
- Molecular Formula:
- C42H41FN8O2
- Molecular Weight:
- 708.83
- MDL Number:
- MFCD34179477
- MOL File:
- 2170606-74-1.mol
- MSDS File:
- SDS
- TDS File:
- TDS
SAFETY
Risk and Safety Statements
| Symbol(GHS) | ![]() GHS07 |
|---|---|
| Signal word | Warning |
| Hazard statements | H302-H315-H319-H335 |
| Precautionary statements | P261-P280-P301+P312-P302+P352-P305+P351+P338 |
DB2313 (DB 2313) price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Biosynth | VLD60674 | DB2313 | 2170606-74-1 | 50mg | $1075 | 2026-06-05 | Buy |
| Biosynth | VLD60674 | DB2313 | 2170606-74-1 | 100mg | $1495 | 2026-06-05 | Buy |
| ChemScene | CS-0087172 | DB2313 99.48% | 2170606-74-1 | 5mg | $162 | 2026-06-04 | Buy |
| ChemScene | CS-0087172 | DB2313 99.48% | 2170606-74-1 | 10mg | $271 | 2026-06-04 | Buy |
| ChemScene | CS-0087172 | DB2313 99.48% | 2170606-74-1 | 25mg | $538 | 2026-06-04 | Buy |
DB2313 (DB 2313) Chemical Properties, Uses, Production
Uses
DB2313 is a potent inhibitor of transcription factor PU.1. DB2313 inhibits PU.1-dependent reporter gene transactivation with an IC50 of 5 μM. DB2313 disrupts the interaction of PU.1 with target gene promoters. DB2313 induces apoptosis in acute myeloid leukemia (AML) cells and has anticancer effects[1].
in vivo
DB2313 (17 mg/kg; i.p.; three times per week; for 3 weeks) treatment decreases leukemia progression and results in increased survival in mice[1].
| Animal Model: | NSG mice bearing sublethally irradiated (2.0 Gy) and injection with PU.1 URE–/– AML cells[1] |
| Dosage: | 17 mg/kg |
| Administration: | Intraperitoneal injection; three times per week; for 3 weeks |
| Result: | Decreased tumor burden and resulted in increased survival. |
References
[1] Iléana Antony-Debré, et al. Pharmacological inhibition of the transcription factor PU.1 in leukemia. J Clin Invest. 2017 Dec 1;127(12):4297-4313. DOI:10.1172/JCI92504
[2] Zhang S, Zhao S, Qi Y, et al. SPI1-induced downregulation of FTO promotes GBM progression by regulating pri-miR-10a processing in an m6A-dependent manner. Mol Ther Nucleic Acids. 2022;27:699-717. DOI:10.1016/j.omtn.2021.12.035
DB2313 (DB 2313) Preparation Products And Raw materials
Raw materials
Preparation Products
DB2313 (DB 2313) Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Shanghai Lollane Biological Technology Co.,Ltd. | 021-52996696,15000506266 15000506266 | China | 4862 | 55 | |
| Shanghai EFE Biological Technology Co., Ltd. | 021-65675885 18964387627 | info@efebio.com | China | 9799 | 58 |
| Shanghai YuanYe Biotechnology Co., Ltd. | 18916372613 | yanzihan@shyuanye.com | China | 87240 | 60 |
| Shanghai SuperLan Chemcial Technique Centre | 0-2022843681 15618226720 | chaolaichem@foxmail.com | China | 9996 | 58 |
| BOC Sciences | 16314854226; +8616314854226 | inquiry@bocsci.com | United States | 19852 | 58 |
| TargetMol Chemicals Inc. | +1-781-999-5354; +1-00000000000 | marketing@targetmol.com | United States | 32431 | 58 |
| ShangHai ChuanQian Chemcial Technique Centre | 15869524721 | 3525679403@qq.com | China | 4565 | 58 |
| Jinan Jiuli Biotechnology Co. , Ltd. | 15865264761 | 486064515@qq.com | China | 4996 | 58 |
| Beijing Jin Ming Biotechnology Co., Ltd. | 010-60605840 | psaitong@jm-bio.com | China | 27756 | 58 |
| Bide Pharmatech Ltd. | 400-1647117 13681763483 | product02@bidepharm.com | China | 59929 | 58 |






